VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It enrolled 120 participants.

Also called NCT04655742

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 120 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04655742
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04655742. Allocation not applicable; no masking; primary purpose treatment. Start 2014-06-27 (actual); primary completion 2017-09-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VitaFlow™ Transcatheter Aortic Valve System Pre-market Trial
Condition
Aortic Valve Stenosis
Intervention (Device)
VitaFlow™ Transcatheter Aortic Valve System
Lead sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct04655742
Content hash
236a8bca59d3ca4a891f6694c912f79c2b0304bd23288f7c51149144260e05d1